These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33762119)

  • 21. Pharmacological inhibition of beta-catenin in hepatoblastoma cells.
    Ellerkamp V; Lieber J; Nagel C; Wenz J; Warmann SW; Fuchs J; Armeanu-Ebinger S
    Pediatr Surg Int; 2013 Feb; 29(2):141-9. PubMed ID: 23266718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GATA4 promotes hepatoblastoma cell proliferation by altering expression of miR125b and DKK3.
    Pei Y; Yao Q; Yuan S; Xie B; Liu Y; Ye C; Zhuo H
    Oncotarget; 2016 Nov; 7(47):77890-77901. PubMed ID: 27788486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting the Neurokinin-1 Receptor Compromises Canonical Wnt Signaling in Hepatoblastoma.
    Ilmer M; Garnier A; Vykoukal J; Alt E; von Schweinitz D; Kappler R; Berger M
    Mol Cancer Ther; 2015 Dec; 14(12):2712-21. PubMed ID: 26516161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Downregulation of transcription factor GATA4 sensitizes human hepatoblastoma cells to doxorubicin-induced apoptosis.
    Soini T; Pihlajoki M; Kyrönlahti A; Andersson LC; Wilson DB; Heikinheimo M
    Tumour Biol; 2017 Mar; 39(3):1010428317695016. PubMed ID: 28349834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Babao Dan is a robust anti-tumor agent via inhibiting wnt/β-catenin activation and cancer cell stemness.
    Xie X; Chen J; Wo D; Ma E; Ning Y; Peng J; Zhu W; Ren DN
    J Ethnopharmacol; 2021 Nov; 280():114449. PubMed ID: 34332067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Huaier Extract Induces Apoptosis in Hepatoblastoma Cells
    Xu DQ; Yuan XJ; Hirayama M; Toyoda H
    In Vivo; 2020; 34(5):2381-2388. PubMed ID: 32871763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidermal growth factor receptor/heme oxygenase-1 axis is involved in chemoresistance to cisplatin and pirarubicin in HepG2 cell lines and hepatoblastoma specimens.
    Kobayashi T; Kubota M; Kinoshita Y; Arai Y; Oyama T; Yokota N; Saito K; Matsuda Y; Osawa M
    Pediatr Surg Int; 2019 Dec; 35(12):1369-1378. PubMed ID: 31559456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased expression of survivin in hepatoblastoma after chemotherapy.
    Uehara S; Oue T; Kawatsu M; Nara K; Fukuzawa M
    Eur J Pediatr Surg; 2013 Oct; 23(5):400-4. PubMed ID: 23444076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The BH3 mimetic ABT-737 increases treatment efficiency of paclitaxel against hepatoblastoma.
    Lieber J; Eicher C; Wenz J; Kirchner B; Warmann SW; Fuchs J; Armeanu-Ebinger S
    BMC Cancer; 2011 Aug; 11():362. PubMed ID: 21854558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment effects of the multikinase inhibitor sorafenib on hepatoblastoma cell lines and xenografts in NMRI-Foxn1 nu mice.
    Eicher C; Dewerth A; Kirchner B; Warmann SW; Fuchs J; Armeanu-Ebinger S
    Liver Int; 2012 Apr; 32(4):574-81. PubMed ID: 22176637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatocyte growth factor protects hepatoblastoma cells from chemotherapy-induced apoptosis by AKT activation.
    Grotegut S; Kappler R; Tarimoradi S; Lehembre F; Christofori G; Von Schweinitz D
    Int J Oncol; 2010 May; 36(5):1261-7. PubMed ID: 20372801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MDM4 inhibition: a novel therapeutic strategy to reactivate p53 in hepatoblastoma.
    Woodfield SE; Shi Y; Patel RH; Chen Z; Shah AP; Srivastava RK; Whitlock RS; Ibarra AM; Larson SR; Sarabia SF; Badachhape A; Starosolski Z; Ghaghada KB; Sumazin P; Annis DA; López-Terrada D; Vasudevan SA
    Sci Rep; 2021 Feb; 11(1):2967. PubMed ID: 33536467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Control of translational activation by PIM kinase in activated B-cell diffuse large B-cell lymphoma confers sensitivity to inhibition by PIM447.
    Peters TL; Li L; Tula-Sanchez AA; Pongtornpipat P; Schatz JH
    Oncotarget; 2016 Sep; 7(39):63362-63373. PubMed ID: 27556513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of IGF2 as Genomic Driver and Actionable Therapeutic Target in Hepatoblastoma.
    Abril-Fornaguera J; Torrens L; Andreu-Oller C; Carrillo-Reixach J; Rialdi A; Balaseviciute U; Pinyol R; Montironi C; Haber PK; Del Río-Álvarez Á; Domingo-Sàbat M; Royo L; Akers NK; Willoughby CE; Peix J; Torres-Martin M; Puigvehi M; Cairo S; Childs M; Maibach R; Alaggio R; Czauderna P; Morland B; Losic B; Mazzaferro V; Guccione E; Sia D; Armengol C; Llovet JM
    Mol Cancer Ther; 2023 Apr; 22(4):485-498. PubMed ID: 36780225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapamycin blocks hepatoblastoma growth in vitro and in vivo implicating new treatment options in high-risk patients.
    Wagner F; Henningsen B; Lederer C; Eichenmüller M; Gödeke J; Müller-Höcker J; von Schweinitz D; Kappler R
    Eur J Cancer; 2012 Oct; 48(15):2442-50. PubMed ID: 22285179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting LRH‑1 in hepatoblastoma cell lines causes decreased proliferation.
    Jin J; Jin J; Woodfield SE; Patel RH; Jin NG; Shi Y; Liu B; Sun W; Chen X; Yu Y; Vasudevan SA
    Oncol Rep; 2019 Jan; 41(1):143-153. PubMed ID: 30320362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro gene targeting in human hepatoblastoma.
    Warmann SW; Armeanu S; Frank H; Buck H; Graepler F; Lemken ML; Heitmann H; Seitz G; Lauer UM; Bitzer M; Fuchs J
    Pediatr Surg Int; 2006 Jan; 22(1):16-23. PubMed ID: 16374644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of β-catenin and Yap1 in human hepatoblastoma and induction of hepatocarcinogenesis in mice.
    Tao J; Calvisi DF; Ranganathan S; Cigliano A; Zhou L; Singh S; Jiang L; Fan B; Terracciano L; Armeanu-Ebinger S; Ribback S; Dombrowski F; Evert M; Chen X; Monga SPS
    Gastroenterology; 2014 Sep; 147(3):690-701. PubMed ID: 24837480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein Translation Inhibition is Involved in the Activity of the Pan-PIM Kinase Inhibitor PIM447 in Combination with Pomalidomide-Dexamethasone in Multiple Myeloma.
    Paíno T; González-Méndez L; San-Segundo L; Corchete LA; Hernández-García S; Díaz-Tejedor A; Algarín EM; Mogollón P; Martín-Sánchez M; Gutiérrez NC; Mateos MV; Garayoa M; Ocio EM
    Cancers (Basel); 2020 Sep; 12(10):. PubMed ID: 32987735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcription factor GATA4 associates with mesenchymal-like gene expression in human hepatoblastoma cells.
    Soini T; Eloranta K; Pihlajoki M; Kyrönlahti A; Akinrinade O; Andersson N; Lohi J; Pakarinen MP; Wilson DB; Heikinheimo M
    Tumour Biol; 2018 Jul; 40(7):1010428318785498. PubMed ID: 30074440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.